A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

SOPHiA-A.D.A.M.

More Like This

PR Newswire associated0

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

From left to right: Dr. Iri Sato Baran, Genesis Healthcare (A.D.A.M Innovations), Vice Chair of the Board Ambassador Julia Longbottom, British Embassy Foreign, Commonwealth and Development Office Michel Mommejat, Genesis Healthcare (A.D.A.M Innovations), CEO and Executive Director Gretchen Weightman, Oxford Nanopore Technologies, Senior Vice President Commercial and General Manager APAC, Dr. Toshiharu Furukawa, LDP, Chair of Medical Information Policy and Genomic Medicine, House of Councillors, Hirokazu Shimoda, Japan Agency for Medical Research and Development, Senior Director

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

PR Newswire associated0

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

PR Newswire associated0

SOPHiA DDM™ Platform Certified Under IVDR

PR Newswire associated0

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

PR Newswire associated0

Seegene Showcased its Multiplex Technology at ADLM 2024

PR Newswire associated0

Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor

PR Newswire associated0

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics